🇺🇸 FDA
Pipeline program

HYCAMTIN 4 mg powder for concentrate for solution for infusion, Trodelvy 200 mg powder for concentrate for solution for infusion

GS-US-600-6165

Phase 3 small_molecule active

Quick answer

HYCAMTIN 4 mg powder for concentrate for solution for infusion, Trodelvy 200 mg powder for concentrate for solution for infusion for Extensive Stage Small Cell Lung Cancer (ES-SCLC) is a Phase 3 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences International Limited
Indication
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials